Plus Therapeutics reported $-6.95M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Baxter International USD 294M 168M Sep/2026
Cerus USD -20.92M 17.98M Dec/2024
Dr.Reddys Laboratories INR 9.25B 4.81B Sep/2026
Haemonetics USD 46.3M 13.3M Sep/2026
Northwest Biotherapeutics USD -3.4M 23.78M Mar/2026
Plus Therapeutics USD -6.95M 1.23M Mar/2026
Sanofi EUR 3.02B 2.68B Sep/2026
Starpharma Holdings AUD 1.37M 3.67M Dec/2025
Sun Pharmaceuticals INR 19.89B 9.06B Sep/2026
Teva Pharmaceutical Industries USD 233M 809M Sep/2026